Solid Biosciences Inc. · NASDAQ:SLDB
Raymond Debbane reported a 9.40% stake in Solid Biosciences Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 12, 2025
Raymond Debbane reported a 9.40% stake in Solid Biosciences Inc., 3,749,041 shares, as a passive investor on Dec 31, 2024. Filed Feb 12, 2025 (Schedule 13G/A).
- Stake
- 9.40%
- Shares
- 3,749,041
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 8 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Invus Public Equities, L.P. | 8.20% | 3,265,927 |
| Invus Public Equities Advisors, LLC | 8.20% | 3,265,927 |
| Invus Global Management, LLC | 8.20% | 3,265,927 |
| Siren, L.L.C. | 8.20% | 3,265,927 |
| Avicenna Life Sci Master Fund LP | 1.20% | 483,114 |
| Avicenna Life Sci Master GP LLC | 1.20% | 483,114 |
| Ulys, L.L.C. | 1.20% | 483,114 |
| Raymond Debbane | 9.40% | 3,749,041 |
Source
Related
- Solid Biosciences Inc.
- Invus Public Equities, L.P.
- Solid Biosciences Inc. shareholders
- Schedule 13G/A · Invus Public Equities, L.P. · May 5, 2026
- Schedule 13G/A · Invus Public Equities, L.P. · Apr 17, 2025
- Form 4 · Smith Ian F · Oct 6, 2026
- Schedule 13D/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Vestal Point Capital, LP · Aug 14, 2026
- Schedule 13G · FMR LLC · Aug 6, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026